Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0144 | 0.2789 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0144 | 0.2789 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0164 | 1 | 1 |
Trypanosoma cruzi | aldehyde dehydrogenase family, putative | 0.0164 | 1 | 0.5 |
Echinococcus granulosus | Fatty aldehyde dehydrogenase | 0.0164 | 1 | 1 |
Onchocerca volvulus | Aldehyde dehydrogenase homolog | 0.0164 | 1 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase (NAD+) dependent | 0.0164 | 1 | 1 |
Trichomonas vaginalis | succinate semialdehyde dehydrogenase, putative | 0.0164 | 1 | 0.5 |
Echinococcus granulosus | aldehyde dehydrogenase family 3 member B1 | 0.0164 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase family 3 member B1 | 0.0164 | 1 | 1 |
Echinococcus multilocularis | Fatty aldehyde dehydrogenase | 0.0164 | 1 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase (NAD+) dependent | 0.0164 | 1 | 1 |
Trypanosoma cruzi | aldehyde dehydrogenase family, putative | 0.0164 | 1 | 0.5 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0144 | 0.2789 | 0.2789 |
Mycobacterium leprae | PROBABLE ALDEHYDE DEHYDROGENASE (NAD+) DEPENDENT | 0.0164 | 1 | 0.5 |
Trypanosoma brucei | aldehyde dehydrogenase family, putative | 0.0164 | 1 | 0.5 |
Entamoeba histolytica | aldehyde dehydrogenase 1, putative | 0.0164 | 1 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0144 | 0.2789 | 0.2789 |
Loa Loa (eye worm) | aldehyde dehydrogenase 4 | 0.0164 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.